US Stock MarketDetailed Quotes

EPIX ESSA Pharma

Watchlist
  • 1.888
  • +0.178+10.41%
Trading Nov 7 11:39 ET
83.81MMarket Cap-3045P/E (TTM)

ESSA Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-17.11%-5.75M
-13.43%-6.82M
-55.06%-6.79M
29.35%-19.78M
39.97%-4.49M
22.34%-4.91M
28.32%-6.01M
24.79%-4.38M
-10.17%-28M
-1.27%-7.48M
Net income from continuing operations
0.89%-7.23M
-27.33%-8.99M
11.53%-5.96M
24.27%-26.58M
13.32%-5.48M
17.31%-7.3M
34.96%-7.06M
25.90%-6.74M
4.62%-35.1M
26.12%-6.32M
Operating gains losses
-130.07%-278.8K
152.72%281.61K
-479.14%-418.51K
97.29%-528
29,638.32%81.48K
-480.43%-121.18K
190.61%111.43K
-158.24%-72.26K
74.28%-19.51K
100.05%274
Depreciation and amortization
-25.56%22.67K
-27.07%22.21K
-24.44%23.01K
-2.71%118.49K
-10.83%27.15K
0.00%30.45K
0.00%30.45K
0.00%30.45K
11.26%121.79K
5.72%30.45K
Other non cash items
470.07%8.71K
371.50%9.17K
185.15%6.7K
104.16%7.32K
102.41%1.5K
-95.79%1.53K
101.69%1.94K
106.70%2.35K
-164.58%-175.91K
-112.39%-62.15K
Change In working capital
-140.58%-618.82K
376.04%946.64K
-211.26%-1.04M
399.89%2.34M
107.63%225.53K
98.68%1.52M
-145.81%-342.94K
41.44%931.75K
-140.07%-780.01K
-175.02%-2.95M
-Change in receivables
125.37%31.58K
-690.01%-34.56K
-440.44%-45.55K
-126.69%-128.85K
-113.32%-1.76K
-1,815.54%-124.51K
120.68%5.86K
-101.67%-8.43K
406.39%482.8K
105.05%13.24K
-Change in prepaid assets
-104.98%-18.59K
-13.99%374.33K
-413.15%-983.07K
236.49%1.23M
108.84%110.17K
-24.68%373.11K
-36.29%435.21K
-27.72%313.93K
164.99%366.26K
27.06%-1.25M
-Change in payables and accrued expense
-147.92%-611.58K
181.27%637.2K
-96.45%22.26K
175.85%1.24M
106.80%117.13K
358.12%1.28M
-936.13%-784.01K
323.70%626.25K
-161.07%-1.63M
-291.93%-1.72M
-Change in other current liabilities
---20.23K
---30.34K
---30.34K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Operating cash flow
-17.11%-5.75M
-13.43%-6.82M
-55.06%-6.79M
29.35%-19.78M
39.97%-4.49M
22.34%-4.91M
28.32%-6.01M
24.79%-4.38M
-10.17%-28M
-1.27%-7.48M
Investing cash flow
Cash flow from continuing investing activities
102.64%23.49K
7,226.00%62.51M
650.98%8.23M
93.35%-3.53M
92.10%-264.65K
92.62%-891.15K
96.71%-877.19K
86.42%-1.49M
-51.52%-53.05M
-3.35M
Net investment purchase and sale
102.64%23.49K
7,226.00%62.51M
650.98%8.23M
93.35%-3.53M
92.10%-264.65K
92.62%-891.15K
96.70%-877.19K
86.43%-1.49M
-51.47%-53.05M
-29,430.60%-3.35M
Cash from discontinued investing activities
Investing cash flow
102.64%23.49K
7,226.00%62.51M
650.98%8.23M
93.35%-3.53M
92.10%-264.65K
92.62%-891.15K
96.71%-877.19K
86.42%-1.49M
-51.52%-53.05M
---3.35M
Financing cash flow
Cash flow from continuing financing activities
172.00%25.58K
1,958.03%643.6K
1,156.45%196.66K
-126.97%-68.16K
60.60%-13.65K
-820.82%-35.52K
-118.91%-34.64K
-84.24%15.65K
-99.82%252.74K
-359.99%-34.64K
Net issuance payments of debt
--0
--0
--0
-2.12%-136.87K
7.43%-32.07K
-2.55%-35.52K
-7.00%-34.64K
-7.00%-34.64K
-33.65%-134.02K
-13.03%-34.64K
Proceeds from stock option exercised by employees
--25.58K
--643.6K
291.04%196.66K
-82.23%68.71K
--18.42K
--0
--0
-61.81%50.29K
-70.71%386.76K
--0
Cash from discontinued financing activities
Financing cash flow
172.00%25.58K
1,958.03%643.6K
1,156.45%196.66K
-126.97%-68.16K
60.60%-13.65K
-820.82%-35.52K
-118.91%-34.64K
-84.24%15.65K
-99.82%252.74K
-359.99%-34.64K
Net cash flow
Beginning cash position
106.96%91.68M
-31.00%35.34M
-40.95%33.7M
-58.59%57.08M
-43.32%38.47M
-48.63%44.3M
-57.69%51.22M
-58.59%57.08M
144.71%137.83M
-53.26%67.87M
Current changes in cash
2.34%-5.7M
913.78%56.33M
128.05%1.64M
71.07%-23.38M
56.11%-4.77M
68.29%-5.83M
80.12%-6.92M
64.98%-5.86M
-199.07%-80.8M
-47.35%-10.86M
Effect of exchange rate changes
-38.41%-1.9K
55.48%4.08K
201.86%438
-95.20%2.46K
-97.60%1.64K
-105.67%-1.37K
-52.08%2.63K
99.08%-430
191.38%51.28K
8,360.37%68.11K
End cash Position
123.53%85.99M
106.96%91.68M
-31.00%35.34M
-40.95%33.7M
-40.95%33.7M
-43.32%38.47M
-48.63%44.3M
-57.69%51.22M
-58.59%57.08M
-58.59%57.08M
Free cash flow
-17.11%-5.75M
-13.43%-6.82M
-55.06%-6.79M
29.35%-19.78M
39.97%-4.49M
22.34%-4.91M
28.32%-6.01M
24.79%-4.38M
-10.17%-28M
-1.27%-7.48M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -17.11%-5.75M-13.43%-6.82M-55.06%-6.79M29.35%-19.78M39.97%-4.49M22.34%-4.91M28.32%-6.01M24.79%-4.38M-10.17%-28M-1.27%-7.48M
Net income from continuing operations 0.89%-7.23M-27.33%-8.99M11.53%-5.96M24.27%-26.58M13.32%-5.48M17.31%-7.3M34.96%-7.06M25.90%-6.74M4.62%-35.1M26.12%-6.32M
Operating gains losses -130.07%-278.8K152.72%281.61K-479.14%-418.51K97.29%-52829,638.32%81.48K-480.43%-121.18K190.61%111.43K-158.24%-72.26K74.28%-19.51K100.05%274
Depreciation and amortization -25.56%22.67K-27.07%22.21K-24.44%23.01K-2.71%118.49K-10.83%27.15K0.00%30.45K0.00%30.45K0.00%30.45K11.26%121.79K5.72%30.45K
Other non cash items 470.07%8.71K371.50%9.17K185.15%6.7K104.16%7.32K102.41%1.5K-95.79%1.53K101.69%1.94K106.70%2.35K-164.58%-175.91K-112.39%-62.15K
Change In working capital -140.58%-618.82K376.04%946.64K-211.26%-1.04M399.89%2.34M107.63%225.53K98.68%1.52M-145.81%-342.94K41.44%931.75K-140.07%-780.01K-175.02%-2.95M
-Change in receivables 125.37%31.58K-690.01%-34.56K-440.44%-45.55K-126.69%-128.85K-113.32%-1.76K-1,815.54%-124.51K120.68%5.86K-101.67%-8.43K406.39%482.8K105.05%13.24K
-Change in prepaid assets -104.98%-18.59K-13.99%374.33K-413.15%-983.07K236.49%1.23M108.84%110.17K-24.68%373.11K-36.29%435.21K-27.72%313.93K164.99%366.26K27.06%-1.25M
-Change in payables and accrued expense -147.92%-611.58K181.27%637.2K-96.45%22.26K175.85%1.24M106.80%117.13K358.12%1.28M-936.13%-784.01K323.70%626.25K-161.07%-1.63M-291.93%-1.72M
-Change in other current liabilities ---20.23K---30.34K---30.34K----------0--0--0--------
Cash from discontinued investing activities
Operating cash flow -17.11%-5.75M-13.43%-6.82M-55.06%-6.79M29.35%-19.78M39.97%-4.49M22.34%-4.91M28.32%-6.01M24.79%-4.38M-10.17%-28M-1.27%-7.48M
Investing cash flow
Cash flow from continuing investing activities 102.64%23.49K7,226.00%62.51M650.98%8.23M93.35%-3.53M92.10%-264.65K92.62%-891.15K96.71%-877.19K86.42%-1.49M-51.52%-53.05M-3.35M
Net investment purchase and sale 102.64%23.49K7,226.00%62.51M650.98%8.23M93.35%-3.53M92.10%-264.65K92.62%-891.15K96.70%-877.19K86.43%-1.49M-51.47%-53.05M-29,430.60%-3.35M
Cash from discontinued investing activities
Investing cash flow 102.64%23.49K7,226.00%62.51M650.98%8.23M93.35%-3.53M92.10%-264.65K92.62%-891.15K96.71%-877.19K86.42%-1.49M-51.52%-53.05M---3.35M
Financing cash flow
Cash flow from continuing financing activities 172.00%25.58K1,958.03%643.6K1,156.45%196.66K-126.97%-68.16K60.60%-13.65K-820.82%-35.52K-118.91%-34.64K-84.24%15.65K-99.82%252.74K-359.99%-34.64K
Net issuance payments of debt --0--0--0-2.12%-136.87K7.43%-32.07K-2.55%-35.52K-7.00%-34.64K-7.00%-34.64K-33.65%-134.02K-13.03%-34.64K
Proceeds from stock option exercised by employees --25.58K--643.6K291.04%196.66K-82.23%68.71K--18.42K--0--0-61.81%50.29K-70.71%386.76K--0
Cash from discontinued financing activities
Financing cash flow 172.00%25.58K1,958.03%643.6K1,156.45%196.66K-126.97%-68.16K60.60%-13.65K-820.82%-35.52K-118.91%-34.64K-84.24%15.65K-99.82%252.74K-359.99%-34.64K
Net cash flow
Beginning cash position 106.96%91.68M-31.00%35.34M-40.95%33.7M-58.59%57.08M-43.32%38.47M-48.63%44.3M-57.69%51.22M-58.59%57.08M144.71%137.83M-53.26%67.87M
Current changes in cash 2.34%-5.7M913.78%56.33M128.05%1.64M71.07%-23.38M56.11%-4.77M68.29%-5.83M80.12%-6.92M64.98%-5.86M-199.07%-80.8M-47.35%-10.86M
Effect of exchange rate changes -38.41%-1.9K55.48%4.08K201.86%438-95.20%2.46K-97.60%1.64K-105.67%-1.37K-52.08%2.63K99.08%-430191.38%51.28K8,360.37%68.11K
End cash Position 123.53%85.99M106.96%91.68M-31.00%35.34M-40.95%33.7M-40.95%33.7M-43.32%38.47M-48.63%44.3M-57.69%51.22M-58.59%57.08M-58.59%57.08M
Free cash flow -17.11%-5.75M-13.43%-6.82M-55.06%-6.79M29.35%-19.78M39.97%-4.49M22.34%-4.91M28.32%-6.01M24.79%-4.38M-10.17%-28M-1.27%-7.48M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data